Diabetes Metabolic Syndrome and Obesity,
Год журнала:
2024,
Номер
Volume 17, С. 575 - 584
Опубликована: Фев. 1, 2024
Background:
Type
2
diabetes
(T2DM)
combined
nonalcoholic
fatty
liver
disease
(NAFLD)
are
characterized
by
metabolic
disruptions.
Liraglutide
has
been
proved
to
be
effective
in
T2DM.
If
LRG
could
regulate
NAFLD
T2DM
not
reported.
Methods:
Intraperitoneal
injection
of
1%
streptozotocin
(STZ)
plus
high-sugar
and
high-fat
diet
was
used
induce
animal
model.
Palmitic
acid
(200
μmol/L)
glucose
(25
mmol/L)
incubation
were
cell
The
apoptosis,
mRNA
protein
expression
measured
through
flow
cytometry,
PCR,
Western
blotting,
respectively.
Results:
significantly
improved
the
injury
rats,
but
Com-C
reversed
effect
liraglutide.
decreased
AMPK/mTOR
signaling
pathway
animals
greatly
activated
protection
effects
liraglutide
on
palmitic
acid+glucose
induced
damage.
Conclusion:
alleviate
damage
caused
NAFLD+T2DM
acid+glucose.
inhibited
suppressing
pathway.
This
research
might
provide
a
novel
therapeutic
strategy
for
prevention
treatment
disease.
Keywords:
type
diabetes,
disease,
liraglutide,
AMPK/mTOR,
autophagy
Annals of Medicine,
Год журнала:
2025,
Номер
57(1)
Опубликована: Фев. 12, 2025
Background
Nonalcoholic
fatty
liver
disease
(NAFLD)
is
a
chronic
and
its
prevalence
has
risen
sharply.
However,
whether
nutrition,
dietary
strategies,
exercise,
lifestyle
environment
have
preventive
value
for
NAFLD
remains
unclear.
Journal of Clinical Medicine,
Год журнала:
2025,
Номер
14(6), С. 1950 - 1950
Опубликована: Март 13, 2025
Background:
An
association
between
education
levels
and
liver
disease
has
been
confirmed,
but
not
yet
with
metabolic
dysfunction-associated
steatotic
(MASLD).
The
aim
is
to
investigate
the
relationship
MASLD
in
two
cohorts
southern
Italy.
Methods:
study
cohort
included
2909
participants
assessed
during
third
recall
of
MICOL
second
NUTRIHEP,
subdivided
into
four
groups
based
on
levels.
Results:
A
strong
protective
was
found
higher
Participants
had
an
OR
=
0.50
(p
<
0.001,
0.36
0.69
95%
C.I.),
0.29
0.21
0.41),
0.24
0.16
0.37
C.I.)
for
middle,
high
school,
graduate
education,
respectively.
Conclusions:
This
study’s
findings
indicate
that
there
linking
level,
i.e.,
having
a
lower
level
increases
risk
disease,
proper
policy
regulate
may
also
mitigate
ever-increasing
problem
this
disease.
PLoS ONE,
Год журнала:
2025,
Номер
20(3), С. e0319851 - e0319851
Опубликована: Март 18, 2025
Objective
Metabolic
-
associated
fatty
liver
disease
(MAFLD)
is
a
common
hepatic
disorder
with
increasing
prevalence,
and
early
detection
remains
inadequately
achieved.
This
study
aims
to
explore
the
relationship
between
non-high-density
lipoprotein
cholesterol
high-density
ratio
(NHHR)
MAFLD,
establish
predictive
model
for
MAFLD
using
NHHR
as
key
variable.
Methods
All
participants
were
selected
from
NHANES
cohort,
spanning
2017
March
2020.
Multiple
linear
regression
models
employed
examine
controlled
attenuation
parameter
(CAP).
To
non-linear
association
CAP,
smooth
curve
fitting
restricted
cubic
splines
(RCS)
of
adjusted
variables
utilized.
Subgroup
analyses
conducted
identify
variations
in
relationships
independent
dependent
across
different
populations.
Finally,
metabolic
prediction
was
developed
seven
machine
learning
methods,
including
eXtreme
Gradient
Boosting
(XGBoost),
Light
Machine
(LightGBM),
Multilayer
Perceptron
(MLP),
Random
Forest,
Support
Vector
(SVM),
K-Nearest
Neighbors
(KNN),
logistic
regression.
The
SHAP
(SHapley
Additive
exPlanations)
value
interpret
importance
various
features.
Result
Weighted
multiple
revealed
significant
positive
correlation
CAP
(Beta
=
7.42,
95%
CI:
5.35-9.50,
P
<
0.001).
Smooth
RCS
demonstrated
CAP.
indicated
that
this
more
pronounced
females.
Among
incorporating
NHHR,
XGBoost
algorithm
exhibited
highest
performance,
an
area
under
(AUC)
0.828.
Furthermore,
identified
second
most
important
feature
analysis,
following
body
mass
index
(BMI),
highlighting
its
potential
predicting
MAFLD.
Conclusion
A
inclusion
robust
capability,
providing
valuable
tool
considerable
clinical
application
potential.
Journal of Translational Medicine,
Год журнала:
2023,
Номер
21(1)
Опубликована: Авг. 21, 2023
Phosphodiesterases
(PDEs)
have
been
associated
with
psychiatric
disorders
in
observational
studies;
however,
the
causality
of
associations
remains
unestablished.Specifically,
cyclic
nucleotide
PDEs
were
collected
from
genome-wide
association
studies
(GWASs),
including
obtained
by
hydrolyzing
both
adenosine
monophosphate
(cAMP)
and
guanosine
(cGMP)
(PDE1A,
PDE2A,
PDE3A),
specific
to
cGMP
(PDE5A,
PDE6D,
PDE9A)
cAMP
(PDE4D
PDE7A).
We
performed
a
bidirectional
two-sample
Mendelian
randomization
(MR)
analysis
investigate
relationship
between
nine
disorders.
The
inverse-variance-weighted
(IVW)
method,
MR-Egger,
weighted
median
used
estimate
causal
effects.
Cochran's
Q
test,
MR-Egger
intercept
MR
Steiger
leave-one-out
analyses,
funnel
plot,
pleiotropy
residual
sum
outlier
(MR-PRESSO)
for
sensitivity
analyses.The
higher-odds
For
example,
PDE4D
schizophrenia
(SCZ)
(odds
ratios
(OR)
=
1.0531,
PIVW
0.0414),
as
well
major
depressive
disorder
(MDD)
(OR
1.0329,
0.0011).
Similarly,
PDE7A
was
higher
odds
attention-deficit/hyperactivity
(ADHD)
1.0861,
0.0038).
Exploring
PDE
subtypes
increase
intracellular
levels
can
inform
development
targeted
interventions.
also
observed
(which
hydrolyzes
cGMP)
[OR
PDE1A
1.0836
autism
spectrum
disorder;
OR
PDE2A
0.8968
Tourette
syndrome
(TS)
0.9449
SCZ;
PDE3A
0.9796
MDD;
P
<
0.05].
Furthermore,
had
some
effects
on
[obsessive-compulsive
increased
PDE6D
decreased
PDE4D;
anorexia
nervosa
PDE9A].
results
found
be
robust
using
multiple
analysis.In
this
study,
potential
relationships
plasma
proteins
established.
other
not
included
study
could
provide
more
comprehensive
understanding
role
medications
targeting
may
promising
therapeutic
approach
treating
Frontiers in Microbiology,
Год журнала:
2023,
Номер
14
Опубликована: Июнь 2, 2023
Introduction
Growing
evidence
indicates
that
variations
in
the
composition
of
gut
microbiota
are
linked
to
onset
and
progression
chronic
respiratory
diseases
(CRDs),
albeit
causal
relationship
between
two
remains
unclear.
Methods
We
conducted
a
comprehensive
two-sample
Mendelian
randomization
(MR)
analysis
investigate
five
main
CRDs,
including
obstructive
pulmonary
disease
(COPD),
asthma,
idiopathic
fibrosis
(IPF),
sarcoidosis,
pneumoconiosis.
For
MR
analysis,
inverse
variance
weighted
(IVW)
method
was
utilized
as
primary
method.
The
MR–Egger,
median,
MR-PRESSO
statistical
methods
were
used
supplement.
To
detect
heterogeneity
pleiotropy,
Cochrane
Rucker
Q
test,
MR–Egger
intercept
global
test
then
implemented.
leave-one-out
strategy
also
applied
assess
consistency
results.
Results
Based
on
substantial
genetic
data
obtained
from
genome-wide
association
studies
(GWAS)
comprising
3,504,473
European
participants,
our
study
offers
several
microbial
taxa,
14
probable
taxa
(specifically,
5,
3,
2,
3
1
for
COPD,
IPF,
pneumoconiosis,
respectively)
33
possible
6,
7,
8,
7
5
play
significant
roles
formation
CRDs.
Discussion
This
work
implies
relationships
thereby
shedding
new
light
microbiota-mediated
prevention
Liver International,
Год журнала:
2024,
Номер
44(3), С. 799 - 810
Опубликована: Янв. 17, 2024
Abstract
Background
and
Aims
Metabolic
dysfunction‐associated
fatty
liver
disease
(MAFLD)
encompasses
heterogeneous
diseases
associated
with
metabolic
disorders.
We
aimed
to
evaluate
the
association
between
MAFLD
extrahepatic
malignancies
based
on
subtypes.
Methods
This
nationwide
cohort
study
included
9
298
497
patients
who
participated
in
a
health‐screening
programme
of
National
Health
Insurance
Service
Korea
2009.
Patients
were
further
classified
into
four
subgroups:
non‐MAFLD,
diabetes
mellitus
(DM)‐MAFLD,
overweight/obese‐MAFLD
lean‐MAFLD.
The
primary
outcome
was
development
any
malignancy,
while
death,
decompensated
cirrhosis
transplantation
considered
competing
events.
secondary
outcomes
all‐cause
malignancy‐related
mortality.
Results
In
total,
2
500
080
diagnosed
MAFLD.
During
median
follow‐up
10.3
years,
447
880
(6.0%)
identified.
DM‐MAFLD
(adjusted
subdistribution
hazard
ratio
[aSHR]
=
1.13;
95%
confidence
interval
[CI]
1.11–1.14;
p
<
.001)
lean‐MAFLD
(aSHR
1.12;
CI
1.10–1.14;
groups
higher
risks
malignancy
than
non‐MAFLD
group.
However,
group
exhibited
similar
risk
compared
1.00;
.99–1.00;
.42).
These
findings
reproduced
several
sensitivity
analyses.
an
independent
factor
for
mortality
[aHR]
1.41;
1.40–1.43;
(aHR
1.20;
1.17–1.23;
.001).
Conclusion
diabetic
or
lean
subtype
non‐MAFLD.
As
comprises
population,
appropriate
stratification
management
subtypes
are
required.
Diabetology & Metabolic Syndrome,
Год журнала:
2024,
Номер
16(1)
Опубликована: Март 5, 2024
Abstract
Background
Type
1
diabetes
mellitus
(T1DM)
has
been
associated
with
higher
pulmonary
tuberculosis
(PTB)
risk
in
observational
studies.
However,
the
causal
relationship
between
them
remains
unclear.
This
study
aimed
to
assess
effect
T1DM
and
PTB
using
bidirectional
Mendelian
randomization
(MR)
analysis.
Methods
Single
nucleotide
polymorphisms
(SNPs)
of
were
extracted
from
public
genetic
variation
summary
database.
In
addition,
GWAS
data
collected
explore
relevant
clinical
traits
T1DM,
including
glycemic
traits,
lipids,
obesity.
The
inverse
variance
weighting
method
(IVW),
weighted
median
method,
MR‒Egger
regression
used
evaluate
relationship.
To
ensure
stability
results,
sensitivity
analyses
robustness
results
by
estimating
heterogeneity
pleiotropy.
Results
IVW
showed
that
increased
(OR
=
1.07,
95%
CI:
1.03–1.12,
P
<
0.001),
which
was
similar
analyses.
Moreover,
we
found
high-density
lipoprotein
cholesterol
(HDL-C;
OR
1.28,
1.03–1.59,
0.026)
PTB.
There
no
evidence
an
remaining
lipid
markers,
or
obesity
on
reverse
MR
analysis,
relationships
detected
for
its
traits.
Conclusion
supported
HDL-C
factors
implies
effective
role
treating
managing
reducing
PTB,
provides
essential
basis
prevention
comanagement
concurrent
practice.